LONDON (Alliance News) - ANGLE PLC on Tuesday said it has been granted patents in China and Australia for the Parsotix cell separation system.
The patents will provide protection over a wide range of uses of the Parsotix technology, the company said.
"The grant of these patents in China and Australia extends ANGLE's protection over the Parsortix separation technology into major new markets. There is strong and growing interest in both China and Australia for liquid biopsies and we anticipate that following Europe and the United States, these will be important markets for Parsortix," said Chief Executive Andrew Newland.
By Sam Unsted; samunsted@alliancenews.com; @SamUAtAlliance
Copyright 2015 Alliance News Limited. All Rights Reserved.
Angle (AGL)